It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 2012.
2012 | Kanpur, Uttar Pradesh, India | ActiveConvira Pharmaceuticals Private Limited, a active private limited company, was established on 30 January 2012 in Kanpur, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74120UP2012PTC048613. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.11 M.
It upholds a compliant status. Its leadership includes Payal Sahu (Director), Sujeet Sahu (Managing Director), Rajesh Sahu (Director). Past directors included Brijesh Agnihotri, Sujeet Sahu. It holds ₹0.95 M open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Raman Villa Apartment, Flat No. 102, 160-E Block, Shyam Nagar,, Kanpur, Uttar Pradesh, 208013.
U74120UP2012PTC048613
048613
30 January 2012
₹0.50 M
₹0.11 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Convira Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Payal Sahu | Director | 30 Jan 2012 | Current |
| Sujeet Sahu | Managing Director | 30 Jan 2012 | Current |
| Rajesh Sahu | Director | 01 Apr 2025 | Current |
| Brijesh Kumar Sahu | Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jun 2014 | Past |
| Pramod Abcsdd | Director | 31 Jan 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Convira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.75% decrease. The company also saw a substantial fall in profitability, with a 56.41% decrease in profit. The company's net worth dipped by a decrease of 1.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Convira Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹950,000.00
₹2,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2021 | Others | ₹0.95 M | Open |
| 27 Jul 2013 | Bank Of India | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Convira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Convira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Convira Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rajesh Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 2 days . was recorded as a recent event.
Progress on Brijesh Kumar Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 2 days . was documented.
The activity Convira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Convira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
A charge with Others amounted to Rs. 0.95 M with Charge ID 100490687 was registered on 27 Sep 2021. was recorded as a recent event.
A charge registered on 27 Jul 2013 via Charge ID 10443619 with Bank Of India was fully satisfied on 22 May 2019. was recorded as a recent event.
The CIN of Convira Pharmaceuticals Private Limited is U74120UP2012PTC048613.
Convira Pharmaceuticals Private Limited is headquartered at Raman Villa Apartment, Flat No. 102, 160-E Block, Shyam Nagar,, Kanpur, Uttar Pradesh, 208013.
Convira Pharmaceuticals Private Limited was incorporated on 30 January 2012.
The current directors of Convira Pharmaceuticals Private Limited are
The primary industry of Convira Pharmaceuticals Private Limited is Trade.
Convira Pharmaceuticals Private Limited is unlisted.
The authorized capital of Convira Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.11 M.
The compliance status of Convira Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX